Skip to main content
GeneralHomeInvestorsNews

MedinCell: mdc-TJK’s (Teva’s codename: TEV-44749) Phase 1 study pharmacokinetics to be presented for the first time by Teva at SIRS 2023 (May 11-15, 2023, Toronto, Canada)

By May 4, 2023March 15th, 2024No Comments1 min read